| CASE REPORT |
|
| Year : 2013 | Volume
: 45
| Issue : 1 | Page : 98-99 |
Olanzapine induced neuroleptic malignant syndrome
Bichitra Nanda Patra1, Sudhir K Khandelwal2, Mamta Sood2
1 Department of Psychiatry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2 Department of Psychiatry, AIIMS, New Delhi, India
Correspondence Address:
Bichitra Nanda Patra
Department of Psychiatry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.106448
An 18 year old male diagnosed as a case of bipolar affective disorder (BPAD), developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. NMS is usually seen with typical antipsychotic drugs. The patient was diagnosed as a case of NMS, offending agent was immediately withdrawn and prompt treatment with bromocriptine and levodopa produced a good recovery. The various features of the case are discussed in view of the potential mortality of the syndrome.
[FULL TEXT] [PDF]*
|
